ATE475099T1 - Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) - Google Patents

Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor)

Info

Publication number
ATE475099T1
ATE475099T1 AT05797120T AT05797120T ATE475099T1 AT E475099 T1 ATE475099 T1 AT E475099T1 AT 05797120 T AT05797120 T AT 05797120T AT 05797120 T AT05797120 T AT 05797120T AT E475099 T1 ATE475099 T1 AT E475099T1
Authority
AT
Austria
Prior art keywords
hgf
growth factor
biological activity
hepatocyte growth
assessment
Prior art date
Application number
AT05797120T
Other languages
English (en)
Inventor
Fariba Nayeri
Original Assignee
Peas Inst Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peas Inst Ab filed Critical Peas Inst Ab
Application granted granted Critical
Publication of ATE475099T1 publication Critical patent/ATE475099T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475Assays involving growth factors
    • G01N2333/4753Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
AT05797120T 2004-10-20 2005-10-20 Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor) ATE475099T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62061004P 2004-10-20 2004-10-20
PCT/SE2005/001583 WO2006043892A1 (en) 2004-10-20 2005-10-20 Assessment of biological activity of hepatocyte growth factor (hgf)

Publications (1)

Publication Number Publication Date
ATE475099T1 true ATE475099T1 (de) 2010-08-15

Family

ID=36203224

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05797120T ATE475099T1 (de) 2004-10-20 2005-10-20 Beurteilung der biologischen aktivität von hgf (hepatocyte growth factor)

Country Status (6)

Country Link
US (1) US20080261233A1 (de)
EP (1) EP1810037B1 (de)
JP (1) JP2008516629A (de)
AT (1) ATE475099T1 (de)
DE (1) DE602005022474D1 (de)
WO (1) WO2006043892A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101360511A (zh) * 2005-11-16 2009-02-04 法里巴·内耶里 用内源c-met配体和抑制剂抑制个体中的癌发生和/或转移的方法
US8545839B2 (en) * 2008-12-02 2013-10-01 Pierre Fabre Medicament Anti-c-Met antibody
EP2446274B1 (de) 2009-06-26 2017-08-09 PEAS Institut AB Verfahren zur bestimmung biologisch aktiver hgf
GB2519329A (en) * 2013-10-16 2015-04-22 Gm Global Tech Operations Inc Method of controlling an exhaust recirculation gas system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000515735A (ja) * 1996-07-03 2000-11-28 ジェネンテック インコーポレーテッド 肝細胞成長因子レセプターアゴニスト
EP1320384B1 (de) 2000-08-28 2007-10-10 Damavand Wound AB Die synergistischen wirkungen von hgf und antibakterieller behandlung
US6818907B2 (en) * 2000-10-17 2004-11-16 The President And Fellows Of Harvard College Surface plasmon enhanced illumination system
SI2949658T1 (sl) * 2003-03-03 2018-10-30 Dyax Corp. Peptidi, ki specifično vežejo HGF receptor (cMet) in njihove uporabe
EP2367008A3 (de) 2003-06-06 2014-12-24 Genentech, Inc. Modulierung der Interaktion zwischen HGF-beta-Kette und C-Met
EP2292915B1 (de) 2005-12-20 2013-07-24 BorgWarner, Inc. Steuerung zur Abgasrückführung in turboaufgeladenen Brennkraftmaschinen

Also Published As

Publication number Publication date
EP1810037B1 (de) 2010-07-21
JP2008516629A (ja) 2008-05-22
EP1810037A1 (de) 2007-07-25
US20080261233A1 (en) 2008-10-23
DE602005022474D1 (de) 2010-09-02
WO2006043892A1 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
BRPI0507680A (pt) partìculas de fosfato de cálcio terapêuticas e métodos de fabricação e uso das mesmas
IL180725A0 (en) Inhibitors of angiopoietin-like 4 protein, combinations, and their use
ATE286118T1 (de) Anwendungen für humane nicht autologe, mesenchymale stammzellen
IL190991A (en) Causes of cardiac infarction and delay of left ventricular remodeling after cardiac infarction containing antibody that identifies IL-6 receptor as active substance
BRPI0618488A2 (pt) proteìnas de fusão de ìntron de fator de crescimento de hepatócito
TW200505478A (en) Immunoglobulin formulation and method of preparation thereof
NO20070293L (no) Aryl-substituerte piperazinderivater
DE602006017071D1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
ATE330468T1 (de) Lösung zur evaluierung und konservierung
DE602005026105D1 (de) Verwendung von agonisten und antagonisten von interleukin-33 (il-33)
BRPI0507812A (pt) sistema de microativação, método para a microativação das células epidérmicas, kit, método para montar o dispositivo de microativação e método para a microativação da pele
SG196821A1 (en) New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein
TW200616632A (en) Compounds modulating c-kit activity and uses therefor
NO20070950L (no) Preparater og fremgangsmater for anvendelse av angiopoietinlignende-4-protein.
ATE531383T1 (de) Therapeutische verwendung eines wachstumsfaktors, metrnl
WO2007143098A3 (en) Hepatocyte growth factor (hgf) binding proteins
BRPI0406605B8 (pt) conjugado de proteína, método para a preparação do mesmo e composição farmacêutica para intensificar a duração e estabilidade in vivo de um polipeptídeo fisiologicamente ativo
WO2007143090A3 (en) Hepatocyte growth factor (hgf) binding proteins
SG161247A1 (en) Variant forms of urate oxidase and use thereof
DE602005010246D1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
DK1709161T3 (da) Humane terapeutiske celler, som udskiller nervevækstfaktor
CY1118073T1 (el) Συνθεσεις και μεθοδοι για την αυξηση της δρασης της τελομερασης
ATE512146T1 (de) Phenylharnstoffderivate als hemmstoffe von tyrosinkinasen zur behandlung von tumorerkrankungen
WO2007005502A3 (en) Methods and compositions for treating diseases targeting cdcp1
DE60235234D1 (de) Hydrogelkugeln oder kapseln als künstliches medium zur eiablage von insekten und zucht von endoparasitoiden

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1810037

Country of ref document: EP